2006 Book Chapter Tumors, malignant: bronchogenic carcinomaFong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, malignant: bronchogenic carcinoma. Encyclopedia of respiratory medicine. (pp. 325-332) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00408-7 |
2006 Conference Publication Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptorsMolenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC. |
2006 Journal Article CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lungLarsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27 (3), 525-532. doi: 10.1093/carcin/bgi227 |
2006 Journal Article Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in QueenslandCoory, M., Fong, K., Bowman, R. and Hall, L. (2006). Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36 (6), 389-392. doi: 10.1111/j.1445-5994.2006.01074.x |
2006 Book Chapter Tumors, malignant: metastases from lung cancerFong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, malignant: metastases from lung cancer. Encyclopedia of respiratory medicine. (pp. 350-356) London, United Kingdom: Elsevier . doi: 10.1016/B0-12-370879-6/00412-9 |
2006 Journal Article Expression and methylation pattern of TSLC1 cascade genes in lung carcinomasHeller, G., Fong, K. M., Girard, L., Seidl, S., End-Pfutzenreuter, A., Lang, G., Gazdar, A. F., Minna, J. D., Zielinski, C. C. and Zochbauer-Muller, S. (2006). Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene, 25 (6), 959-968. doi: 10.1038/sj.onc.1209115 |
2006 Other Outputs Bronchogenic CarcinomaBowman, R. V., Zimmerman, P. V. and Fong, K. M. (2006). Bronchogenic Carcinoma. |
2006 Book Chapter Tumors, malignant: overviewFong, K. M., Zimmerman, P. V. and Bowman, R. V. (2006). Tumors, malignant: overview. Encyclopedia of respiratory medicine. (pp. 320-325) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00406-3 |
2006 Book Chapter Hematological MalignanciesWood, P. and Fong, K. M. (2006). Hematological Malignancies. Encyclopedia of Respiratory Medicine. (pp. 339-344) edited by Geoffrey J. Laurent and Steven D. Shapiro. New York: Academic Press (Elsevier). doi: 10.1016/B0-12-370879-6/00410-5 |
2006 Other Outputs Tumors, Malignant: Carcinoma, Lymph Node InvolvementFong, K. M., Windsor, M., Bowman, R. V. and Duhig, E. (2006). Tumors, Malignant: Carcinoma, Lymph Node Involvement. |
2006 Other Outputs Tumors, Malignant: Metastases from Lung CancerFong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, Malignant: Metastases from Lung Cancer. |
2006 Book Chapter Tumors, malignant: carcinoma, lymph node involvementFong, K. M., Windsor, M., Bowman, R. V. and Duhig, E. (2006). Tumors, malignant: carcinoma, lymph node involvement. Encyclopedia of respiratory medicine. (pp. 366-373) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00407-5 |
2006 Book Chapter TUMORS, MALIGNANT | Metastases from Lung CancerFong, K. M., Clarke, B. E. and Bowman, R. V. (2006). TUMORS, MALIGNANT | Metastases from Lung Cancer. Encyclopedia of Respiratory Medicine: Volume 1-4. (pp. V4-350-V4-356) Elsevier. doi: 10.1016/B0-12-370879-6/00412-9 |
2006 Other Outputs Tumors, Malignant: Bronchogenic CarcinomaFong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Bronchogenic Carcinoma. |
2005 Journal Article Cochrane systematic reviews of treatments for lung cancerFong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002 |
2005 Journal Article Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylationZochbauer-Muller, Sabine, Fong, Kwun M., Geradts, Joseph, Xu, Xie, Seidl, Sonja, End-Pfützenreuter, Adelheid, Lang, György, Heller, Gerwin, Zielinski, Christoph C., Gazdar, Adi F. and Minna, John D. (2005). Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene, 24 (41), 6249-6255. doi: 10.1038/sj.onc.1208775 |
2005 Journal Article Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphismLarsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3 |
2005 Journal Article An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown originTothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D.L. and Holloway, A.J. (2005). An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65 (10), 4031-4040. doi: 10.1158/0008-5472.CAN-04-3617 |
2005 Journal Article Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancersShigematsu, Hisayuki, Lin, Li, Takahashi, Takao, Nomura, Masaharu, Suzuki, Makoto, Wistuba, Ignacio I., Fong, Kwun M., Lee, Huei, Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Feng, Ziding, Roth, Jack A., Herz, Joachim, Minna, John, D. and Gazdar, Adi, F. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute, 97 (5), 339-346. doi: 10.1093/jnci/dji055 |
2005 Journal Article Somatic mutations of the HER2 kinase domain in lung adenocarcinomasShigematsu, Hisayuki, Takahashi, Takao, Nomura, Masaharu, Majmudar,Kuntal, Suzuki, Makoto, Lee, Huei, Wistuba, Ignacio I., Fong, Kwun M., Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Minna, John D. and Gazdar, Adi F. (2005). Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Research, 65 (5), 1642-1646. doi: 10.1158/0008-5472.CAN-04-4235 |